APOE and Alzheimer disease: The ordering of the CSF biomarkers in amyloid+ and APOE+ individuals supports the ordering of CSF biomarkers predicted by earlier hypothetical models of Alzheimer’s disease progression: CSF amyloid-β1–42, phosphorylated tau, total tau.